Literature DB >> 24527763

Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

N Percie du Sert1, A S C Rice.   

Abstract

Neuropathic pain remains an area of considerable unmet clinical need. Research based on preclinical animal models has failed to deliver truly novel treatment options, questioning the predictive value of these models. This review addresses the shortcomings of rodent in vivo models commonly used in the field and highlights approaches which could increase their predictivity, including more clinically relevant assays, outcome measures and animal characteristics. The methodological quality of animal studies also needs to be improved. Low internal validity and incomplete reporting lead to a waste of valuable research resources and animal lives, and ultimately prevent an objective assessment of the true predictivity of in vivo models.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  analgesic; animal model; neuropathic pain; preclinical model; translation

Mesh:

Substances:

Year:  2014        PMID: 24527763      PMCID: PMC4055199          DOI: 10.1111/bph.12645

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  131 in total

1.  Novel, nonreflex tests detect analgesic action in rodents at clinically relevant concentrations.

Authors:  Nick Andrews; Sinead Harper; Yasmin Issop; Andrew S C Rice
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 2.  What should we be measuring in behavioral studies of chronic pain in animals?

Authors:  Jeffrey S Mogil; Sara E Crager
Journal:  Pain       Date:  2004-11       Impact factor: 6.961

3.  Social modulation of pain as evidence for empathy in mice.

Authors:  Dale J Langford; Sara E Crager; Zarrar Shehzad; Shad B Smith; Susana G Sotocinal; Jeremy S Levenstadt; Mona Lisa Chanda; Daniel J Levitin; Jeffrey S Mogil
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

4.  Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy.

Authors:  V K Kontinen; T Kauppila; S Paananen; A Pertovaara; E Kalso
Journal:  Pain       Date:  1999-03       Impact factor: 6.961

5.  Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques.

Authors:  Victoria A Laast; Beom Shim; Lisa M Johanek; Jamie L Dorsey; Peter E Hauer; Patrick M Tarwater; Robert J Adams; Carlos A Pardo; Justin C McArthur; Matthias Ringkamp; Joseph L Mankowski
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

6.  Description of a short-term Taxol-induced nociceptive neuropathy in rats.

Authors:  N Authier; J P Gillet; J Fialip; A Eschalier; F Coudore
Journal:  Brain Res       Date:  2000-12-29       Impact factor: 3.252

7.  Age-related impact of neuropathic pain on animal behaviour.

Authors:  Gisèle Pickering; Didier Jourdan; Magali Millecamps; Eric Chapuy; Josette Alliot; Alain Eschalier
Journal:  Eur J Pain       Date:  2006-01-20       Impact factor: 3.931

8.  Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.

Authors:  M J Field; R J Oles; A S Lewis; S McCleary; J Hughes; L Singh
Journal:  Br J Pharmacol       Date:  1997-08       Impact factor: 8.739

Review 9.  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors:  Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

10.  The assessment of post-vasectomy pain in mice using behaviour and the Mouse Grimace Scale.

Authors:  Matthew C Leach; Kristel Klaus; Amy L Miller; Maud Scotto di Perrotolo; Susana G Sotocinal; Paul A Flecknell
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

View more
  72 in total

1.  Rethinking risk assessment for emerging technology first-in-human trials.

Authors:  Anna Genske; Sabrina Engel-Glatter
Journal:  Med Health Care Philos       Date:  2016-03

2.  Progress in pain medicine: where are we now?

Authors:  Lesley A Colvin; Andrew S C Rice
Journal:  Br J Anaesth       Date:  2019-06-04       Impact factor: 9.166

3.  Development of a spontaneously active dorsal root ganglia assay using multiwell multielectrode arrays.

Authors:  Kim Newberry; Shuya Wang; Nina Hoque; Laszlo Kiss; Michael K Ahlijanian; James Herrington; John D Graef
Journal:  J Neurophysiol       Date:  2016-04-06       Impact factor: 2.714

Review 4.  Neuropathic pain and spasticity: intricate consequences of spinal cord injury.

Authors:  N B Finnerup
Journal:  Spinal Cord       Date:  2017-07-11       Impact factor: 2.772

Review 5.  The emergence of animal models of chronic pain and logistical and methodological issues concerning their use.

Authors:  Terence J Coderre; André Laferrière
Journal:  J Neural Transm (Vienna)       Date:  2019-11-18       Impact factor: 3.575

6.  Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain.

Authors:  Andrew J Shepherd; Bryan A Copits; Aaron D Mickle; Páll Karlsson; Suraj Kadunganattil; Simon Haroutounian; Satya M Tadinada; Annette D de Kloet; Manouela V Valtcheva; Lisa A McIlvried; Tayler D Sheahan; Sanjay Jain; Pradipta R Ray; Yuriy M Usachev; Gregory Dussor; Eric G Krause; Theodore J Price; Robert W Gereau; Durga P Mohapatra
Journal:  J Neurosci       Date:  2018-07-05       Impact factor: 6.167

7.  Attenuation of Unevoked Mechanical and Cold Pain Hypersensitivities Associated With Experimental Neuropathy in Mice by Angiotensin II Type-2 Receptor Antagonism.

Authors:  Andrew J Shepherd; Durga P Mohapatra
Journal:  Anesth Analg       Date:  2019-06       Impact factor: 5.108

8.  Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel.

Authors:  Ya-Kun Huang; Yu-Gang Lu; Xin Zhao; Jing-Bing Zhang; Feng-Ming Zhang; Yong Chen; Ling-Bo Bi; Jia-Hui Gu; Zuo-Jie Jiang; Xiao-Man Wu; Qing-Yi Li; Yanli Liu; Jian-Xin Shen; Xing-Jun Liu
Journal:  Br J Pharmacol       Date:  2020-11-16       Impact factor: 8.739

9.  Macrophage angiotensin II type 2 receptor triggers neuropathic pain.

Authors:  Andrew J Shepherd; Aaron D Mickle; Judith P Golden; Madison R Mack; Carmen M Halabi; Annette D de Kloet; Vijay K Samineni; Brian S Kim; Eric G Krause; Robert W Gereau; Durga P Mohapatra
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-06       Impact factor: 11.205

10.  Peripherally Acting μ-Opioid Receptor Agonists Attenuate Ongoing Pain-associated Behavior and Spontaneous Neuronal Activity after Nerve Injury in Rats.

Authors:  Vinod Tiwari; Michael Anderson; Fei Yang; Vineeta Tiwari; Qin Zheng; Shao-Qiu He; Tong Zhang; Bin Shu; Xueming Chen; Shaness A Grenald; Kimberly E Stephens; Zhiyong Chen; Xinzhong Dong; Srinivasa N Raja; Yun Guan
Journal:  Anesthesiology       Date:  2018-06       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.